Spruce Biosciences Reports Q2 2024 Results And Corporate Updates
12 Aug 2024 //
BUSINESSWIRE
Spruce`s Tildacerfont PCOS Phase 2 POWER Results At ENDO 2024
03 Jun 2024 //
BUSINESSWIRE
Spruce and Kaken Announce Partnership to DevelopTildacerfont for CAH in Japan
05 Jan 2023 //
BUSINESSWIRE
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022
24 Jan 2022 //
BUSINESSWIRE
Spruce Biosciences to Announce Phase 1 and 2 Data of Tildacerfont
02 Mar 2021 //
BIOSPACE